Biolife Solutions Inc Stock
Your prediction
Biolife Solutions Inc Stock
There is no change in the price for Biolife Solutions Inc today.
Pros and Cons of Biolife Solutions Inc in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biolife Solutions Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biolife Solutions Inc | 0.000% | 5.512% | 18.584% | 41.053% | 27.619% | 54.023% | -31.317% |
| Pacira Pharmaceuticals | 0.890% | 1.802% | 5.607% | 20.856% | 4.630% | -31.515% | -53.689% |
| Supernus Pharmaceuticals | 0.500% | -1.429% | 5.612% | 45.775% | -3.721% | 51.095% | 78.448% |
| Collegium Pharmaceutical Inc | -0.650% | -1.274% | 1.974% | 15.672% | -25.121% | 58.163% | 47.619% |
News
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
Key Points
- Interested in Repligen Corporation? Here are five stocks we like better.
- Repligen is acquiring BioLife Solutions in a deal valued at about $1.5 billion, paying $31 per share in a
